Mouse models for microphthalmia, anophthalmia and cataracts

  • Jochen GrawEmail author
Open Access
Original Investigation
Part of the following topical collections:
  1. Eye Genetics


Mouse mutants are a long-lasting, valuable tool to identify genes underlying eye diseases, because the absence of eyes, very small eyes and severely affected, cataractous eyes are easily to detect without major technical equipment. In mice, actually 145 genes or loci are known for anophthalmia, 269 for microphthalmia, and 180 for cataracts. Approximately, 25% of the loci are not yet characterized; however, some of the ancient lines are extinct and not available for future research. The phenotypes of the mutants represent a continuous spectrum either in anophthalmia and microphthalmia, or in microphthalmia and cataracts. On the other side, mouse models are still missing for some genes, which have been identified in human families to be causative for anophthalmia, microphthalmia, or cataracts. Finally, the mouse offers the possibility to genetically test the roles of modifiers and the role of SNPs; these aspects open new avenues for ophthalmogenetics in the mouse.


Blindness in children is a very severe condition affecting ~ 14 million children worldwide (Solebo et al. 2017). Among them, cataracts are the major subgroup affecting 28% of the cases (Solebo et al. 2017); the prevalence of congenital cataracts ranges from 0.32 to 22.9/10,000 children in different geographic regions over the world (Sheeladavi et al. 2016). Similarly, the prevalence of anophthalmia/microphthalmia has been estimated between 0.2 and 3.0 per 10,000 births (summarized by Llorente-González et al. 2011) with an incidence of congenital anophthalmia (in England) ranging from 0.4 to 2.9 per 100,000 infants and an incidence of congenital microphthalmia ranging from 10.0 to 10.8 per 100,000 children (Dharmasena et al. 2017). Although these eye disorders are rare, they represent a major challenge for the treating clinicians and for the families, who have to fight the diseases. Discussing the reasons for such severe disorders, we have to consider prenatal environmental factors such as intrauterine infections or toxins, but also genetic reasons. Here, we will focus on these genetic aspects leading to anophthalmia, microphthalmia or congenital cataracts. Summaries of the human cases have been published recently (e.g. Reis and Semina 2015; Anand et al. 2018); therefore, in this review, I will concentrate on mouse models, because the mouse is genetically the best characterized mammalian model system for hereditary diseases, particularly, if they affect the eye.

Anophthalmia, severe microphthalmia and congenital cataracts are indicators of major disturbances during early embryonic eye development. Briefly, in mice, eye development starts around embryonic day 9.5, when the lens placode thickens getting close to the underlying neural ectoderm of the diencephalon. The lens placode invaginates forming the future lens; thereby, it separates from the surface ectoderm, which will form the future cornea. At the same time, when the lens placode invaginates, also the underlying neural ectoderm of the diencephalon invaginates, and its inner part will form the various layers of the neural retina, whereas the outer part will give rise to the retinal pigment epithelium. When the mouse is born, lens and cornea are fully developed, but the eye lids are still closed, and the retina needs another 2 weeks to maturation. Two weeks after birth, the mice open their eyes and they are ready for life. More detailed reviews on the molecular mechanisms of eye development have been published recently (Anand and Lachke 2017; Cvekl et al. 2015; Reis and Semina 2015; Graw 2010).

Anophthalmia and severe microphthalmia are mainly caused by aberrations during early eye development; in human ophthalmogenetics, they are discussed frequently together with coloboma as “microphthalmia, anophthalmia, coloboma spectrum” (Reis and Semina 2015). However, colobomata are very specific defects of the formation and closure of the choroid fissure. Even if defects in the choroid fissure are responsible for up to 10% of pediatric blindness (Bernstein et al. 2018), it is rather difficult to find it in mice. Only a few mouse mutant lines are known like the Pax2 mutants suffering from the renal coloboma syndrome, because Pax2 is expressed not only in the developing eye, but also in the kidney leading eventually to defects in both organs, if mutated (Favor et al. 1996). Actually, 12 Pax2 alleles are listed in the MGI database, and in 5 of them, the renal coloboma syndrome has been reported (

Anophthalmia, severe microphthalmia and strong cataracts are easily to detect in the mouse by investigators and, therefore, they are discussed together here. It is not surprising that some of the first mouse mutants with such severe eye defects were published already in the first half of the twentieth century (Little and Bagg 1923; Hertwig 1942). Later, several systematic screens were conducted using ionizing radiation or ethyl-nitroso urea (ENU) as mutagenic agents to identify disease-causing genes including genes leading to eye disorders (Kratochvilova 1981; Ehling et al. 1985; Hrabé de Angelis and Balling 1998; Acevedo-Arozena et al. 2008; Clark et al. 2004; Aigner et al. 2011). These programs have been very successful in the identification of novel genes; today, ENU screens to detect novel genes are still performed at the Riken Center (Japan; and by the Bench-to-Bassinet program (b2b; However, targeted and/or conditional mutagenesis is performed nowadays more frequently to better understand the underlying mechanisms during mammalian eye development. Another source for the identification of novel genes involved in early eye development is the mouse phenotyping centers, which systematically screen targeted knockout mutants for a broad variety of pathological phenotypes including the eye ( The review here summarizes the genetic characterizations of mouse mutants suffering from microphthalmia, anophthalmia, and cataracts—models leading to a better understanding of eye development in mammals. New resources will be discussed to complete the mosaic.


Anophthalmia is the most severe phenotype, which might occur during eye development, since it indicates that eye development stopped at a very early stage in one or both eyes. In humans, the genetic cause for anophthalmia (and severe microphthalmia) can be identified in ~ 80% of cases because of mutations in SOX2 or OTX2 (Williamson and FitzPatrick 2014). For the mouse, the mammalian phenotype ontology annotation lists 145 genes being associated with anophthalmia (just 28 mutations are unknown). Some of them, e.g. Rax, Sox2, Pax6, Lhx2 and two Bmp genes (Bmp4 and Bmp7) are well characterized in the mouse.

One of the early anophthalmic mouse mutants was identified by Herman Chase (1944) and referred to as eyeless (gene symbol ey). It took almost 60 years, till the mutation was characterized: it is a point mutation affecting the Rax gene (retina and anterior neural fold homeobox); it changes the Met at pos. 10 to Leu (M10L) (Tucker et al. 2001). The Raxey allele is hypomorphic, since the homozygous mutants are fully viable; in contrast, the homozygous knockout mutants of Rax are perinatally lethal (Mathers et al. 1997). The reason for this difference could be the type of the mutation leading to a conservative exchange of Met by Leu, which also affects an alternative, but in-frame translational start site. The authors argue that the Raxey allele leads to a reduced translation, but not to a real null allele (Tucker et al. 2001).

Another important gene for mammalian eye development is Sox2 [SRY (sex-determining region Y)-box 2]. Mutations in human SOX2 lead to anophthalmia, but most mutations are de novo mutations, which appear in the parental germline, and most of the affected persons are sterile (Fantes et al. 2003; Ragge et al. 2005; Bakrania et al. 2007). Therefore, it is not surprising that no spontaneous mouse mutant of this gene exists. On the other hand, several targeted mouse mutants are available: most of them act as hypomorphic alleles (Sox2LP, Sox2IR, Sox2EGFP/IR and Sox2EGFP/LP) and show a range of eye phenotypes from mild microphthalmia to severe anophthalmia. The Sox2EGFP mutant is a full knockout with the enhanced GFP replacing the coding sequence of the Sox2 gene. The Sox2LP allele contains a loxP site 5′ of the locus, and the Sox2IR has IRES and dsRED2 coding sequenced instead of the 3′-UTR of the Sox2 gene. Both alleles show < 40% activity as compound heterozygotes (Sox2EGFP/IR and Sox2EGFP/LP). The severity of the phenotype depends on the remaining Sox2 expression suggesting a dose-dependent function of Sox2 during early eye development (Taranova et al. 2006).

The classical paradigm for anophthalmia in the mouse, however, is the homozygous Pax6 mutants (paired box 6), which do not develop eyes in homozygous mutants (Fig. 1a). The first mouse mutant suffering from a Pax6 mutation was detected as a dominant homozygous lethal mutation with a “small-eye” phenotype as heterozygotes (gene symbol Sey; Roberts 1967); the homozygous Sey mutants die perinatally. Another small-eye phenotype was found in 1975 at Harwell (UK) among offspring whose parents (fathers) have been treated by irradiation. Both mutations, Sey and SeyH (for Harwell), were mapped to mouse chromosome 2 and shown to be allelic (Hogan et al. 1986). Finally, the Sey-mutation was identified as a G→T transversion in codon 194 of the Pax6 gene changing the corresponding position in the protein from a Gly to a stop codon, which results in a premature termination before the homeobox domain. The SeyH allele was characterized by a major deletion affecting not only Pax6, but also some adjacent genes (Hill et al. 1991). In the meantime, the MGI database lists 17 alleles of the mouse Pax6 genes including homozygous viable and fertile hypomorphic alleles. The missense and nonsense mutations are summarized in Fig. 1b; it is surprising that most of the missense mutations are hypomorphs (five out of six), whereas among nine nonsense mutations just one is hypomorphic. Moreover, several splice-site mutations and minor or major deletions are listed in the MGI database. It might be of interest in our context here, that five Pax6 alleles are associated with coloboma (Del(2)Pax611Neu, Pax6132 − 14Neu, Pax6Sey − Dey, Pax6Sey − H, Pax6Sey and Pax6tm1.2Xzh; This allelic series of different phenotypes indicates the need to investigate more than just a knockout of a given gene to see the full spectrum, of which mutations in a given gene might be responsible for—to model also the variability in human genetics.

Fig. 1

Anophthalmia mouse mutant. a Head of a neonatal (P1) homozygous Pax6Aey11 mutant compared to a wild-type mouse (wt) at the same age. The absence of eyes in the mutant is obvious. The eyelids of neonatal mice are still closed (photography: Jana Löster†, unpublished). b The major structural domains of the transcription factor PAX6 are the paired domain (with a N-terminal and C-terminal subdomain; here referred to as PAI—RED), a linker region to the homeodomain (HD), and finally a proline–serine–threonine-rich sequence (P/S/T); the amino acid position at the beginning and the end of the domains are given according to UniProtKB—P63015 (PAX6_MOUSE; feature viewer) for the canonical PAX6 protein of 422 amino acids (i.e. without exon 5a). Point mutations with amino acid exchanges are depicted above the scheme, and point mutations leading to premature stop codons are given below (not to scale). The allele names and the positions of the changed amino acids are given according to the MGI database; the amino acid positions in the database were re-calculated for the canonical protein without exon 5a, if necessary. Hypomorphic mutations are given in purple. Mutations leading to hybrid proteins (splice-site mutations, deletions, insertions) are not shown

Pax6 is the vertebrate homolog of the eyeless gene (ey) in Drosophila. Since the mouse Pax6 gene is able to ectopically express a compound eye at the antennae of Drosophila, the dogma of different routes in evolution for a vertebrate lensed eye vs an ommitidial eye in Drosophila was skipped at least for the underlying genetic regulation (Halder et al. 1995).

Moreover, in mammals, Pax6 is expressed also in other organs, particularly in the brain and in the pancreas. In the brain, it is involved in the regulation of neurogenesis, cell proliferation and patterning effects (Haubst et al. 2004), and in the pancreas, it participates in the regulation of α-cell development (Dames et al. 2010). Therefore, Pax6 might be considered also as a major example of pleiotropic effects. Similarly, Bmp4 mutant mice have been considered as models for urinary system disease and atrioventricular septal defects, and Bmp7 mutants as models for osteoarthritis (MGI database). However, in much more mutant lines affecting the genes discussed in this section, altered phenotypes are observed for many tissues and organs besides the eye.


Microphthalmia or small eyes seem to be a more frequent, but also a rather variable phenotype in the mouse. The mammalian phenotype ontology annotations in the Mouse Genome Informatics (MGI) database contain 505 genotypes of 269 genes; 64 of them are unknown. There are significant overlaps with anophthalmia (e.g. mutation in Pax6, Bmp4, Bmp7) as well as with cataracts (e.g. mutations affecting genes coding for crystallins or connexins).

One of the early mouse mutants suffering from microphthalmia (gene symbol mi) was found by Paula Hertwig (1942) in a mouse cohort originating from irradiated mice; this particular mutation, however, most likely occurred spontaneously in the cohort (Arnheiter 2010). Today, we know that this mutation affects the Mitf gene coding for the microphthalmia-associated transcription factor (also referred to as melanogenesis-associated transcription factor). The mi mutation is characterized by the loss of an Arg residue at the C-terminal part of the DNA-binding domain (Hodgkinson et al. 1993). In the meantime, many alleles of Mitf have been described in the mouse, and the phenotypic range of the mutations is very broad—from dominant phenotypes as in the Mi allele to recessive phenotypes with almost no pathological effect (as in the spotted allele). Among them, three alleles are reported to be associated with colobomata. However, the microphthalmia phenotype occurs mainly in the homozygous mutants; since this transcription factor is expressed in many tissues and cell types including melanocytes, it affects also the skin or hair color. An excellent overview about this allelic series of the different mutations in the Mitf gene was published by Steingrímsson et al. (2004); it is a powerful example of the broad variability of disease-causing variations in a given gene.

Mutations in another gene coding for a transcription factor lead also to interesting phenotypic features—not only for microphthalmia. It is Pitx3, coding for the paired-like homeodomain transcription factor 3 (Fig. 2). The first mutant line, in which this gene was affected, was reported as aphakia (gene symbol ak); it is a spontaneous recessive mutation showing a severe microphthalmia in homozygous mutants (Varnum and Stevens 1968). Later, it turned out that the phenotype was caused by two major deletions in the promotor region of the Pitx3 gene leading eventually to a classical null allele (Semina et al. 2000; Rieger et al. 2001). This mutation stops lens development at the stage of the lens vesicle; it does not detach from the surface ectoderm (the future cornea) and is degraded rapidly. The empty space is filled by hyperproliferating retinal tissue (Semina et al. 2000). The rapid degradation of the developing lens is due to reduced proliferation and increased apoptosis in the ak lenses (Medina-Martinez et al. 2009); Another allele (gene symbol: eyl—eyeless) of the mouse Pitx3 gene is an insertion of a G after cDNA position 416 (416insG; exon 4). The shifted open reading frame is predicted to result in a hybrid protein still containing the PITX3 homeobox, but followed by 121 new amino acids. Since Pitx3 is also expressed in the substantia nigra of the brain, this mutation affects also the formation of dopaminergic neurons in the substantia nigra; Pitx3 mouse mutant lines are, therefore, an excellent model for Parkinson’s disease (Rosemann et al. 2010). Another spontaneous Pitx3 mutant line (gene symbol miak—microphthalmia and aphakia) has a nonsense mutation (Tyr148X) leading to a truncation of PITX3 lacking the OAR domain (Wada et al. 2014); its phenotype is quite similar to ak and eyl.

Fig. 2

Morphology of the eyeless mouse—a model for microphthalmia. a The mutant mice have closed eyelids with very small eyes (microphthalmia). be Heterozygous and homozygous eyeless mutants are compared at embryonic day 14.5. In the upper panel, it is obvious that the eye of the homozygous mutant (c) is much smaller than the wild-type eye (b). In the lower panel, a transverse section through the eye is given (H/E staining): in contrast to the regularly formed wild-type eye (d), the eye of the homozygous mutants (e) is highly disorganized: the cornea is thicker, the lens is largely missing (only a remnant is present), and the retina is hypertrophic filling most of the vitreous body. Bar = 250 µm. C cornea, L lens, ON optic nerve, R retina.

Modified, from Rosemann et al. 2010, with permission from Springer Science + Business Media, LLC 2009

Moreover, it turned out in later experiments that one of the target genes being regulated by PITX3 is Foxe3. The phenotype of a spontaneous Foxe3 mutation, dysgenic lens (gene symbol dyl), resembles very much the ak phenotype, which can be easily explained by this interaction (Ahmad et al. 2013). Besides their phenotypical similarity, one of the interesting common features of the Pitx3 and the Foxe3 mutations is the loss of crystallin expression and the downregulation of Prox1 (Anand and Lachke 2017). Since it is well known that PROX1 activates directly the expression of γ-crystallin genes (and SIX3 inhibits their expression; Lengler et al. 2001), we could consider an activating cascade from PITX3 to Foxe3; in turn, FOXE3 could activate Prox1, and when expressed, its encoded transcription factor leads to an increased γ-crystallin expression. It is a testable hypothesis explaining a “no lens phenotype”, and it would be interesting to see the entire network of this transcription factor-mediated signaling cascade. Since the mouse phenotype of Pitx3 mutations is quite different from the human situation, in which dominant anterior-segment dysgenesis and cataracts are the predominant phenotypes of PITX3 mutations, differences in this signaling cascade might be expected between mouse and man to explain this discrepancy.

In humans, the retinoic acid synthesis pathway including the genes ALDH1A3 (aldehyde dehydrogenase 1 family, member A3; OMIM 600463), RARB (retinoic acid-binding receptor B; OMIM 601972) and STRA6 (stimulated by retinoic acid 6; OMIM 610745) was discussed being one of the major causes of microphthalmia or even anophthalmia (Williamson and FitzPatrick 2014). Surprisingly, in the mouse, mutations in these genes are not involved into corresponding clinical features. Several mouse mutant lines are available for Aldh1a3, and they suffer from various eye diseases, but microphthalmia is not a term, which is used to characterize their phenotype. In contrast, increased corneal stroma thickness or increased total retina thickness are some of their features ( Similarly, the mouse Rarb mutants show ocular disorders including colobomata and cataracts, but no microphthalmia or anophthalmia. Moreover, Stra6 mouse mutants revealed malformations in the choroid and retinal pigmented epithelium; the length of the rod outer segments was shortened, and the number of cone photoreceptors was reduced. Interestingly, treatment of Stra6−/− mice with pharmacological doses of vitamin A rescued their vision (Amengual et al. 2014). Taking these findings together, it suggests that there are major differences between mice and humans concerning the importance of the retinoic acid pathway for the eye development.

There is a further group of mouse mutants, which are characterized by similar types of blebs in combination with microphthalmia: blebbed (bl; Phillips 1970), head blebs (heb; Varnum and Vox 1981), eye blebs (eb; Chapman and Hummel 1963), myelencephalic blebs (my; Little and Bagg 1923), and fetal hematoma (fh; Center 1965); unfortunately, the fh mutant line became extinct before it could be molecularly characterized. The other four mutant lines carry mutations in genes coding for extracellular matrix proteins. The first one, bl, was identified in an F3 screen of a radiation genetics experiment and characterized by reduced eyes and clubbed feet. Later on, the reduced eyes were characterized as cryptophthalmos (fusion of eyelids), associated with distal limb defects. Finally, it turned out that the underlying mutation affects the Fras1 gene (Fraser extracellular matrix complex subunit 1). The underlying mutation in the bl/bl mice was characterized as a nonsense mutation (7313C→A; S2200X) within the 47th exon of the Fras1 gene (McGregor et al. 2003). The Fras1 gene is expressed in many organs; its expression in the lens seems to be causative for the eye malformation in the bl mutant line. The my mutant line arose also in a radiation genetics experiment (Little and Bagg 1923) and exhibits a similar phenotype like bl (cryptophthalmos, and distal limb defects). By a series of genetic testing, this mutation was eventually mapped to Frem2 (Fras1-related extracellular matrix protein 2), however, without showing the causative mutation in this particular gene (Jadeja et al. 2005). The eb mutants show also a recessive mode of inheritance and a similar phenotype like the my mutants (Chapman and Hummel 1963). Takamiya et al. (2004) demonstrated that a deletion of exons 10 and 11 of the Grip1 gene (glutamate receptor interacting protein 1) is responsible for the eye bleb phenotype. The 4th mutant line of this series was heb, which is characterized by absent or malformed eyes; cryptophthalmos is always present in these mutants. The mutation in this particular line affects the gene Frem1 encoding the Fras1-related extracellular matrix protein 1. The causative mutation is a LINE1 insertion 41 bp from the end of exon 17 (Smyth et al. 2004). In an ENU-induced mutation of similar phenotype (bat), the authors identified another causative mutation of the Frem1 gene, close to the splice donor site of intron 25 leading to skipping of exon 25, a frame shift and a premature stop codon in exon 26. These mutant lines demonstrate the genetic heterogeneity of this phenotype, but they are now also considered being excellent models for the human Fraser syndrome, which is characterized as “cryptophthalmos with syndactyly” (Ramsing et al. 1990).


Cataract mutants in the mouse are easy to detect, either by the naked eye, if the lens opacity is total and severe, or by a slit lamp, which is a routine, non-invasive device in ophthalmology and since decades also applied in mouse ophthalmogenetics (Kratochvilova 1981). Therefore, the mammalian phenotype ontology annotations count a similar high number of cataract genotypes like for microphthalmia, namely 459 genotypes. Among them, there are 138 genes listed with targeted mutations, 54 genes with point mutations or small InDels (partially overlapping) and 50 loci with unknown mutations.

Before the onset of major genetic screens for eye diseases, there were some spontaneous cataract mutants reported. Dominant cataracts were the Fraser Cataract (CatFr; Fraser and Schabtach 1962), eye lens obsolescence (Elo; Oda et al. 1980), lens opacity (Lop; Lyon et al. 1981) or the Philly cataract (Phil, Kador et al. 1980). Among the recessive cataracts, the Nakano cataract (nct; Fukui et al. 1976) and the vacuolated lens (vl; Dickie 1967) were well known. In this group, the Philly cataract was the first, which was characterized at a molecular level: the mutation is a 12-bp deletion at the beginning of the 6th exon of the Crybb2 gene (coding for βB2-crystallin; Chambers and Russell 1991).

The crystallins are highly concentrated and densely packed structural proteins in the eye lens; they are necessary for lens transparency. In mammals, we know two major crystallin families: the α-crystallin/small heat-shock protein family (consisting of two genes, Cryaa and Cryab), and the β/γ-crystallin “super”family (consisting of eight Cryg genes and six Cryb genes). Mutations in each of these genes lead to several forms of cataract; however, there is no genotype–phenotype correlation possible beside the association between the onset of the crystallin expression in the lens and the age of onset of the disease: cataracts caused by mutations in Cryg genes are visible at weaning (for a review see Graw 2009), but mutations in the Crybb2 gene lead to a progressive cataract starting a few weeks after birth (Kador et al. 1980; Ganguly et al. 2008). Mutations in the Cryb/Cryg genes, usually, lead to a dominant phenotype; however, Cryaa mutations may cause dominant (Aey7: c371T→A, Val124Glu; Graw et al. 2001) or recessive cataracts (lop18: c161G→A; Arg54His; Chang et al. 1999).

In the past, the different crystallin-encoding genes were believed to be expressed in the lens only; however, we learned during the last years that many of these genes have also other functions outside the lens. The mouse mutations in the Cryab gene (encoding αB-crystallin) showed not only cataracts, but also other diseases, affecting mainly the heart, but also skeletal muscle fibers (Andley et al. 2011). Similarly, the gene of the major β-crystallin, Crybb2, is expressed in the testes leading to subfertility if mutated (DuPrey et al. 2007). Crybb2 is also expressed in the brain (Magabo et al. 2000; Ganguly et al. 2008), and in homozygous Crybb2 mutants, parvalbumin-positive interneurons as well as dendrites and dendritic branches in the hippocampus are decreased (Sun et al. 2013, 2018), and eventually changes in schizophrenia-related endophenotypes have been observed (Heermann et al. 2018).

Another major group of cataract mutations in the mouse affects the Gja8 gene (gap junction α8) coding for connexin50, which is one of the components of lens gap junctions (besides connexin43 and connexin46; for review see Gong et al. 2007; Berthoud and Ngezahayo 2017). Point mutations in the Gja8 gene lead to early-onset, dominant cataracts, whereas the knockout of this gene has a milder phenotype; however, since also gap junctions are formed by different combinations of the three connexins at different regions of the lens, the types of cataracts formed are highly diverse (Gong et al. 2007).

Among the spontaneously arisen cataract mutants, the CatFr and Lop mutations have been shown to be allelic soon after their discovery. The molecular analyses revealed point mutations in the gene encoding the major intrinsic protein (Mip) of the lens (also known as aquaporin 0). The CatFr mutation was demonstrated to be the result of a transposon-induced splicing error that substitutes a long terminal repeat sequence for the carboxy-terminus of MIP. The Lop mutation is characterized as a c151G → C exchange leading to a non-conservative exchange, Ala51Pro (Shiels and Bassnett 1996).

Besides structural proteins such as crystallins or membrane proteins, oxidative stress and perturbation in lens glutathione homeostasis are frequently discussed being causative mechanisms for cataract formation (for reviews see Lou 2003; Fan et al. 2017). Along this line, a mutation (c3816T→A) in the Pxdn gene encoding peroxidasin was characterized leading to a premature stop codon. Morphologically, the mutant mice suffer from congenital cataracts because of a disorganized lens matrix and ruptures of the lens capsule; lens cells are present in the anterior chamber as well as in the posterior vitreous body (Yan et al. 2014).

The recessive cataract mutations, nct and vl, have been characterized moleculary, too: The Nakano cataract (nct) is characterized by a mutation affecting the Cpox gene encoding the coproporphyrinogen oxidase (Mori et al. 2013). The mutation vl was eventually characterized by an 8-bp deletion affecting the gene Gpr161 coding for a G-coupled receptor (Matteson et al. 2008).

Cataractous lenses of the mouse are frequently reported to be smaller than wild-type lenses (e.g. Graw et al. 1990a, b, 2004). Since the lens defines the size of the entire eye, also the entire eye is obviously smaller. Correspondingly, there is a group of mouse mutants, which are characterized as heterozygotes by a smaller size of the lens as determined by laser-interference biometry (Puk et al. 2006). At least some of these mutants develop cataracts later in life (e.g. mutation in Cryba2, encoding βA2-crystallin; Puk et al. 2011a) or in homozygotes [(e.g. mutation in Lim2, encoding the lens intrinsic membrane protein 2; Puk et al. 2011b, or a mutation in Ercc2 (excision repair cross-complementing rodent repair deficiency, complementation group 2); Kunze et al. 2015; Fig. 3]. Therefore, it would be an interesting question, whether a reduced lens size might be an early biomarker for cataract formation at later stages in life. Mouse mutants are a valuable tool to test this hypothesis.

Fig. 3

Cataracts in Ercc2Rco015 mutant mice. a Lenses of 5-week-old wild types, hetero- and homozygous RCO015 mutants are prepared and photographed. The lenses of wild types are completely clear; the lenses of heterozygous mutants demonstrate opacities at the capsule, and in the homozygous mutants clear boundaries in the cortical areas are observed in addition to the nuclear opacity. The lenses of homozygous mutants are smaller (bar: 500 µm). b The lens thickness was determined using the established optical low coherence interferometry technique (Puk et al. 2006). It turned out that the lenses of the homozygous Ercc2 mutants (both males and females at the age of 25 weeks) are more than 20% smaller (p < 0.001) than the lenses of heterozygous mutants or wild-type littermates. The quantitative data of the lens thickness are given in a box-and-whisker plot; the whiskers give the 1st and 3rd quartiles, and the bar in the middle of the box indicates the median of the axial length. (Oana Amarie, unpublished data of the German Mouse Clinic, GMC). c Scheimpflug imaging of the same lenses as shown in a demonstrates the clear lenses in wild types and heterozygotes; the opacity in the nuclear region of homozygous mutants is clearly visible above the slightly opaque background of the entire lens (bar: 1000 µm). d The quantitative data of the lens density of the Scheimpflug images are given in a box-and-whisker plot; the whiskers give the 1st and 3rd quartiles, and the bar in the middle of the box indicates the median of the lens density (from Kunze et al. 2015, with permission from the authors)

In addition to mouse models for congenital, childhood or juvenile cataracts, a few mutant lines exist also for senile cataracts. One group of such mutants is the senescent-accelerated mice (SAM) having been developed at the Kyoto university since 1970 (Takeda et al. 1981). Two of the SAM-lines develop also cataracts (SAM1P, Nishimoto et al. 1993; SAM9P; Ashida et al. 1994). Unfortunately, the underlying mutation(s) have not yet been described for these mutant lines. Similarly, the EMORY mouse is also well recognized as a genetic model for age-related cataracts (Kuck et al. 1981–1982). There were several interesting ultrastructural and biochemical data reported like the specific upregulation of the adhesion-related kinase (AKR; Sheets et al. 2002), or—more recently—regional changes of AQP0-dependent square array junction and gap junctions (Biswas et al. 2014), but also for this mutant line the underlying mutation for the dominant mode of inheritance (Kuck et al. 1981/1982) remains to be elaborated.

Missing mutants and unknown mutations

Analyzing the Mouse Genome Informatics (MGI) database on mouse mutants ( for genes involved in anophthalmia, microphthalmia and cataracts, it is obvious that a remarkable number of discovered and phenotypically described mutants is not yet characterized at the molecular level (Table 1). Unfortunately, some of the older mouse lines are already extinct, but others are still available. Using the advanced sequencing techniques including whole exome sequencing, resolving of the remaining “old” mutant lines should be possible fast.

Table 1

Unsolved mutants for anophthalmia/microphthalmia and microphthalmia/cataract

Gene symbol



Strain available (if and where)



Anterior lenticonus with microphthalmia



Anophthalmia, microphthalmia




Anophthalmia, microphthalmia




Anophthalmia, microphthalmia




Cyclops, anophthalmia, microphthalmia




Anophthalmia, microphthalmia




Enophthalmia, anophthalmia, microphthalmia




Anophthalmia, microphthalmia




Brain hernia

Brain hernia








Cataract 3








Dense cataract and microphthalmia




Eye lids open at birth



Exencephaly with severe microphthalmia/anophthalmia




Eyeless 2




Eyeless 3




Eyeless 4




Eyeless 2 Jackson





Iris anomaly with cataract




Iris dysplasia with cataract




Juvenile recessive cataract




Lens cloudy

Harwell, EMMA


Lid gap

Lid gap




Cataract, microphthalmia




Polar cataract and small eyes




Cataract, microphthalmia




Cataract, microphthalmia




Cataract, microphthalmia




Cataract, microphthalmia




Total cataract with microphthalmia






Data are from the Mammalian Phenotype Ontology Associations of the Mouse Genome Informatics database ( using the search terms “anophthalmia”, “microphthalmia” and “cataract” (Sept. 25, 2018)

Resources for mouse mutants:

EMMA The European Mouse Mutant Archive; c/o Helmholtz Center Munich, Institute of Experimental Genetics; Neuherberg/Germany;

HMGU Helmholtz Center Munich, Institute of Developmental Genetics; Neuherberg/Germany;

JAX The Jackson Laboratory, Bar Harbor, USA;

RIKEN Riken BioResource Research Center, Tsukuba/Japan;

Harwell MRC Harwell; Harwell Science and Innovation Campus, Harwell/UK;

Nevertheless, comparing the numbers of genes identified in the mouse for eye diseases discussed here with the genes affected in humans, the number of mouse genes is much lower. For cataracts, the CatMap ( lists 324 cataract genes in humans, but the corresponding list of the mouse comprises just the half or 50% of the human cataract genes still need a mouse model. Unfortunately, no similar databases exist for genes involved in human anophthalmia or microphthalmia. The modern CRISPR/Cas9 technology (Knowlton and Smith 2017) offers one efficient possibility for designing new mutant alleles for interesting disease-causing mutations. Another option would be searching an archive of mouse mutations induced by ENU (e.g., re-deriving the mutants from frozen sperms and checking for the suggested phenotype.

Mouse mutant lines are today also systematically analyzed for their phenotypes ( Worldwide, 18 institutions are collaborating in the International Mouse Phenotyping consortium ( screening also for eye anomalies. First results have been published recently (Moore et al. 2018), and actual results can be found on the IMPC website looking for “eye morphology”. However, there is no way to check directly for terms such as anophthalmia, microphthalmia or cataract. Instead, mouse mutations can be found on the MGI database searching for diseases discussed in this review using the corresponding gene-ontology terms (

Finally, the mouse offers the possibility to genetically test also for the roles of modifiers and for the role of SNPs—these aspects open new avenues for ophthalmogenetics in the mouse.


A wide range of mouse models for microphthalmia, anophthalmia and cataracts have been described in detail and molecularly characterized. However, for many mouse mutant lines the underlying mutation still needs to be identified. However, for many genes, which have been shown to be involved in human anophthalmia, microphthalmia or cataracts, the corresponding mouse model still needs to be established.



I would like to thank Dr. Oana Amarie and Dr. Claudia Dalke for re-evaluating of some figures and for critical reading of the manuscript.

Compliance with ethical standards

Conflict of interest

The author states that there is no conflict of interest.


  1. Acevedo-Arozena A, Wells S, Potter P, Kelly M, Cox RD, Brown SD (2008) ENU mutagenesis, a way forward to understand gene function. Annu Rev Genom Hum Genet 9:49–69CrossRefGoogle Scholar
  2. Ahmad N, Aslam M, Muenster D, Horsch M, Khan MA, Carlsson P, Beckers J, Graw J (2013) Pitx3 directly regulates Foxe3 during early lens development. Int J Dev Biol 57:741–751CrossRefGoogle Scholar
  3. Aigner B, Rathkolb B, Klempt M, Wagner S, Michel D, Klaften M, Laufs J, Schneider B, Sedlmeier R, Hrabé de Angelis M, Wolf E (2011) Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in hematological parameters. Mamm Genome 22:495–505CrossRefGoogle Scholar
  4. Amengual J, Zhang N, Kemerer M, Maeda T, Palczewski K, Von Lintig J (2014) STRA6 is critical for cellular vitamin A uptake and homeostasis. Hum Mol Genet 23:5402–5417CrossRefGoogle Scholar
  5. Anand D, Lachke SA (2017) Systems biology of lens development: a paradigm for disease gene discovery in the eye. Exp Eye Res 156:22–33CrossRefGoogle Scholar
  6. Anand D, Agrawal SA, Slavotinek A, Lachke SA (2018) Mutation update of transcription factor genes FOXE. HSF4, MAF, and PITX3 causing cataracts and other developmental ocular defects. Hum Mutat 3(39):471–494CrossRefGoogle Scholar
  7. Andley UP, Hamilton PD, Ravi N, Weihl CC (2011) A knock-in mouse model for the R120G mutation of αB-crystallin recapitulates human hereditary myopathy and cataracts. PLoS One 6:e17671CrossRefGoogle Scholar
  8. Arnheiter H: The discovery of the microphthalmia locus and its gene, Mitf. Pigment Cell Melanoma Res. 2010 (6):729–735Google Scholar
  9. Ashida Y, Takeda T, Hosokawa M (1994) Protein alterations in age-related cataract associated with a persistent hyaloid vascular system in senescence-accelerated mouse (SAM). Exp Eye Res 59:467–473CrossRefGoogle Scholar
  10. Bakrania P, Robinson DO, Bunyan DJ, Salt A, Martin A, Crolla JA, Wyatt A, Fielder A, Ainsworth J, Moore A, Read S, Uddin J, Laws D, Pascuel-Salcedo D, Ayuso C, Allen L, Collin JR, Ragge NK (2007) SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol 91:1471–1476CrossRefGoogle Scholar
  11. Bernstein CS, Anderson MT, Gohel C, Slater K, Gross JM, Agarwala S (2018) The cellular bases of choroid fissure formation and closure. Dev Biol 440:137–151CrossRefGoogle Scholar
  12. Berthoud VM, Ngezahayo A (2017) Focus on lens connexins. BMC Cell Biol 18(Suppl 1):6. CrossRefGoogle Scholar
  13. Biswas SK, Brako L, Gu S, Jiang JX, Lo WK (2014) Regional changes of AQP0-dependent square array junction and gap junction associated with cortical cataract formation in the Emory mutant mouse. Exp Eye Res 127:132–142CrossRefGoogle Scholar
  14. Center EM (1965) fh - fetal hematoma. Mouse News Lett 33:79–80Google Scholar
  15. Chambers C, Russell P (1991) Deletion mutation in an eye lens beta-crystallin. An animal model for inherited cataracts. J Biol Chem 266:6742–6746Google Scholar
  16. Chang B, Hawes NL, Roderick TH, Smith RS, Heckenlively JR, Horwitz J, Davisson MT (1999) Identification of a missense mutation in the αA-crystallin gene of the lop18 mouse. Mol Vis 5:21Google Scholar
  17. Chapman DB, Hummel KP (1963) Eye blebs (eb). Mouse News Lett 28:32Google Scholar
  18. Chase HB (1944) Studies on an anophthalmic strain of mice. IV. A second major gene for anophthalmia. Genetics 29:264–269Google Scholar
  19. Clark AT, Goldowitz D, Takahashi JS, Vitaterna MH, Siepka SM, Peters LL, Frankel WN, Carlson GA, Rossant J, Nadeau JH, Justice MJ (2004) Implementing large-scale ENU mutagenesis screens in North America. Genetica 122:51–64CrossRefGoogle Scholar
  20. Cvekl A, McGreal R, Liu W (2015) Lens Development and crystallin gene expression. Prog Mol Biol Transl Sci 134:129–167CrossRefGoogle Scholar
  21. Dames P, Puff R, Weise M, Parhofer KG, Göke B, Götz M, Graw J, Favor J, Lechner A (2010) Relative roles of the different Pax6 domains for pancreatic cell development. BMC Dev Biol 10:39. CrossRefGoogle Scholar
  22. Dharmasena A, Keenan T, Goldacre R, Hall N, Goldacre MJ (2017) Trends over time in the incidence of congenital anophthalmia, microphthalmia and orbital malformation in England: database study. Br J Ophthalmol 101:735–739CrossRefGoogle Scholar
  23. Dickie MM (1967) Vacuolated lens. Mouse News Lett 36:39–40Google Scholar
  24. DuPrey KM, Robinson KM, Wang Y, Taube JR, Duncan MK (2007) Subfertility in mice harboring a mutation in βB2-crystallin. Mol Vis 13:366–373Google Scholar
  25. Ehling UH, Charles DJ, Favor J, Graw J, Kratochvilova J, Neuhäuser-Klaus A, Pretsch W (1985) Induction of gene mutations in mice: the multiple endpoint approach. Mutat Res 150:393–401CrossRefGoogle Scholar
  26. Fan X, Monnier VM, Whitson J (2017) Lens glutathione homeostasis: discrepancies and gaps in knowledge standing in the way of novel therapeutic approaches. Exp Eye Res 156:103–111CrossRefGoogle Scholar
  27. Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, Howard-Peebles PN, Hayward C, Vivian AJ, Williamson K, van Heyningen V, FitzPatrick DR: mutations in SOX2 cause anophthalmia. Nat Genet. 2003, 33:461–463CrossRefGoogle Scholar
  28. Favor J, Sandulache R, Neuhäuser-Klaus A, Pretsch W, Chatterjee B, Senft E, Wurst W, Blanquet V, Grimes P, Spörle R, Schughart K (1996) The mouse Pax2 1Neu mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc Natl Acad Sci USA 93:13870–13875CrossRefGoogle Scholar
  29. Fraser FC, Schabtach G (1962) ‘Shrivelled’, a hereditary degeneration of the lens in the house mouse. Genet Res 3:383–387CrossRefGoogle Scholar
  30. Fukui HN, Obazawa H, Kinoshita JH (1976) Lens growth in the Nakano mouse. Invest Ophthalmol 15:422–425Google Scholar
  31. Ganguly K, Favor J, Neuhäuser-Klaus A, Sandulache R, Puk O, Beckers J, Horsch M, Schädler S, Vogt Weisenhorn D, Wurst W, Graw J (2008) Novel allele of Crybb2 in the mouse and its expression in the brain. Invest Ophthalmol Vis Sci 49:1533–1541CrossRefGoogle Scholar
  32. Gong X, Cheng C, Xia CH (2007) Connexins in lens development and cataractogenesis. J Membr Biol 218:9–12CrossRefGoogle Scholar
  33. Graw J (2009) Genetics of crystallins: cataract and beyond. Exp Eye Res 88:173–189CrossRefGoogle Scholar
  34. Graw J (2010) Eye development. Curr Top Dev Biol 90:343–386CrossRefGoogle Scholar
  35. Graw J, Bors W, Gopinath PM, Merkle S, Michel C, Reitmeir P, Schäffer E, Summer KH, Wulff A (1990a) Characterization of Cat-2 t, a radiation-induced dominant cataract mutation in mice. Invest Ophthalmol Vis Sci 31:1353–1361Google Scholar
  36. Graw J, Werner T, Merkle S, Reitmeir P, Schäffer E, Wulff A (1990b) Histological and biochemical characterization of the murine cataract mutant Nop. Exp Eye Res 50:449–456CrossRefGoogle Scholar
  37. Graw J, Löster J, Soewarto D, Fuchs H, Meyer B, Reis A, Wolf E, Balling R, Hrabé de Angelis M (2001) Characterization of a new, dominant V124E mutation in the mouse aA-crystallin-encoding gene. Invest Ophthalmol Vis Sci 42:2909–2915Google Scholar
  38. Graw J, Neuhäuser-Klaus A, Klopp N, Selby PB, Löster J, Favor J (2004) Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse. Invest Ophthalmol Vis Sci 45:1202–1213CrossRefGoogle Scholar
  39. Halder C, Callaerts P, Gehring WJ (1995) Induction of ectopic eyes by targeted expression of the eyeless gene in. Drosoph Sci 267:1788-l 792CrossRefGoogle Scholar
  40. Haubst N, Berger J, Radjendirane V, Graw J, Favor J, Saunders GF, Stoykova A, Götz M (2004) Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development. Development 131:6131–6140CrossRefGoogle Scholar
  41. Heermann T, Garrett L, Wurst W, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Graw J, Hölter SM (2018) Crybb2 mutations consistently affect schizophrenia endophenotypes in mice. Mol Neurobiol. Google Scholar
  42. Hertwig P (1942) Neue Mutationen und kopplungsgruppen bei der Hausmaus. Z. induct. Abstammungs- u Vererbungsl 80:220–246Google Scholar
  43. Hill RE, Favor J, Hogan BL, Ton CC, Saunders GF, Hanson IM, Prosser J, Jordan T, Hastie ND, van Heyningen V (1991) Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 354:522–525 (erratum in: Nature. 1992, 355:750)CrossRefGoogle Scholar
  44. Hodgkinson CA, Moore KJ, Nakayama A, Steingrímsson E, Copeland NG, Jenkins NA, Arnheiter H (1993) Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395–404CrossRefGoogle Scholar
  45. Hogan BL, Horsburgh G, Cohen J, Hetherington CM, Fisher G, Lyon MF (1986) Small eyes (Sey): a homozygous lethal mutation on chromosome 2 which affects the differentiation of both lens and nasal placodes in the mouse. J Embryol Exp Morphol 97:95–110Google Scholar
  46. Hrabé de Angelis M, Balling R (1998) Large scale ENU screens in the mouse: genetics meets genomics. Mutat Res 400:25–32CrossRefGoogle Scholar
  47. Jadeja S, Smyth I, Pitera JE, Taylor MS, van Haelst M, Bentley E, McGregor L, Hopkins J, Chalepakis G, Philip N, Perez Aytes A, Watt FM, Darling SM, Jackson I, Woolf AS, Scambler PJ (2005) Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. Nat Genet 37:520–525CrossRefGoogle Scholar
  48. Kador PF, Fukui HN, Fukushi S, Jernigan HM Jr, Kinoshita JH (1980) Philly mouse: a new model of hereditary cataract. Exp Eye Res 30:59–68CrossRefGoogle Scholar
  49. Knowlton MN, Smith CL (2017) Naming CRISPR alleles: endonuclease-mediated mutation nomenclature across species. Mamm Genome 28:367–376CrossRefGoogle Scholar
  50. Kratochvilova J (1981) Dominant cataract mutations detected in offspring of gamma-irradiated male mice. J Hered 72:302–307CrossRefGoogle Scholar
  51. Kuck JF, Kuwabara T, Kuck KD (1981–1982) The Emory mouse cataract: an animal model for human senile cataract. Curr Eye Res 1:643–649Google Scholar
  52. Kunze S, Dalke C, Fuchs H, Klaften M, Rössler U, Hornhardt S, Gomolka M, Puk O, Sabrautzki S, Kulka U, Hrabě de Angelis M, Graw J (2015) New mutation in the mouse Xpd/Ercc2 gene leads to recessive cataracts. PLoS One 10:e0125304CrossRefGoogle Scholar
  53. Lengler J, Krausz E, Tomarev S, Prescott A, Quinlan RA, Graw J (2001) Antagonistic action of Six3 and Prox1 at the g-crystallin promoter. Nucleic Acids Res 29:515–526CrossRefGoogle Scholar
  54. Little CC, Bagg HJ (1923) The occurrence of two heritable types of abnormality among descendants of X-rayed mice. Am J Roentgenol 10:975–989Google Scholar
  55. Llorente-González S, Peralta-Calvo J, Abelairas-Gómez JM (2011) Congenital anophthalmia and microphthalmia: epidemiology and orbitofacial rehabilitation. Clin Ophthalmol 5:1759–1765CrossRefGoogle Scholar
  56. Lou MF (2003) Redox regulation in the lens. Prog Retin Eye Res 22:657–682CrossRefGoogle Scholar
  57. Lyon MF, Jarvis SE, Sayers I, Holmes RS (1981) Lens opacity: a new gene for congenital cataract on chromosome 10 of the mouse. Genet Res 38:337–341CrossRefGoogle Scholar
  58. Magabo KS, Horwitz J, Piatigorsky J, Kantorow M (2000) Expression of bB2-crystallin mRNA and protein in retina, brain, and testis. Invest Ophthalmol Vis Sci 41:3056–3060Google Scholar
  59. Mathers PH, Grinberg A, Mahon KA, Jamrich M (1997) The Rx homeobox gene is essential for vertebrate eye development. Nature 387:603–607CrossRefGoogle Scholar
  60. Matteson PG, Desai J, Korstanje R, Lazar G, Borsuk TE, Rollins J, Kadambi S, Joseph J, Rahman T, Wink J, Benayed R, Paigen B, Millonig JH (2008) The orphan G protein-coupled receptor, Gpr161, encodes the vacuolated lens locus and controls neurulation and lens development. Proc Natl Acad Sci USA 105:2088–2093CrossRefGoogle Scholar
  61. McGregor L, Makela V, Darling SM, Vrontou S, Chalepakis G, Roberts C, Smart N, Rutland P, Prescott N, Hopkins J, Bentley E, Shaw A, Roberts E, Mueller R, Jadeja S, Philip N, Nelson J, Francannet C, Perez-Aytes A, Megarbane A, Kerr B, Wainwright B, Woolf AS, Winter RM, Scambler PJ (2003) Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet 34:203–208CrossRefGoogle Scholar
  62. Medina-Martinez O, Shah R, Jamrich M (2009) Pitx3 controls multiple aspects of lens development. Dev Dyn 238:2193–2201CrossRefGoogle Scholar
  63. Moore BA, Leonard BC, Sebbag L, Edwards SG, Cooper A, Imai DM, Straiton E, Santos L, Reilly C, Griffey SM, Bower L, Clary D, Mason J, Roux MJ, Meziane H, Herault Y, International Mouse Phenotyping Consortium, McKerlie C, Flenniken AM, Nutter LMJ, Berberovic Z, Owen C, Newbigging S, Adissu H, Eskandarian M, Hsu CW, Kalaga S, Udensi U, Asomugha C, Bohat R, Gallegos JJ, Seavitt JR, Heaney JD, Beaudet AL, Dickinson ME, Justice MJ, Philip V, Kumar V, Svenson KL, Braun RE, Wells S, Cater H, Stewart M, Clementson-Mobbs S, Joynson R, Gao X, Suzuki T, Wakana S, Smedley D, Seong JK, Tocchini-Valentini G, Moore M, Fletcher C, Karp N, Ramirez-Solis R, White JK, de Angelis MH, Wurst W, Thomasy SM, Flicek P, Parkinson H, Brown SDM, Meehan TF, Nishina PM, Murray SA, Krebs MP, Mallon AM, Lloyd KCK, Murphy CJ, Moshiri A (2018) Identification of genes required for eye development by high-throughput screening of mouse knockouts. Commun Biol 1:236. CrossRefGoogle Scholar
  64. Mori M, Gotoh S, Taketani S, Hiai H, Higuchi K (2013) Hereditary cataract of the Nakano mouse: Involvement of a hypomorphic mutation in the coproporphyrinogen oxidase gene. Exp Eye Res 112:45–50CrossRefGoogle Scholar
  65. Nishimoto H, Uga S, Miyata M, Ishikawa S, Yamashita K (1993) Morphological study of the cataractous lens of the senescence accelerated mouse. Graefes Arch Clin Exp Ophthalmol 231:722–728CrossRefGoogle Scholar
  66. Oda S, Watanabe K, Fujisawa H, Kameyama Y (1980) Impaired development of lens fibers in genetic microphthalmia, eye lens obsolescence, Elo, of the mouse. Exp Eye Res 31:673–681CrossRefGoogle Scholar
  67. Phillips RJS (1970) Blebbed, bl. Mouse News Lett 42:26Google Scholar
  68. Puk O, Dalke C, Favor J, Hrabé de Angelis M, Graw J (2006) Variations of eye size parameters among different strains of mice. Mamm Genome 17:851–857CrossRefGoogle Scholar
  69. Puk O, Ahmad N, Wagner S, Hrabé de Angelis M, Graw J (2011a) First mutation in the βA2-crystallin encoding gene is associated with small lenses and age-related cataracts. Invest Ophthalmol Vis Sci 52:2571–2576CrossRefGoogle Scholar
  70. Puk O, Ahmad N, Wagner S, Hrabé de Angelis M, Graw J (2011b) Microphakia and congenital cataract formation in a novel Lim2(C51R) mutant mouse. Mol Vis 17:1164–1171Google Scholar
  71. Ragge NK, Lorenz B, Schneider A, Bushby K, de Sanctis L, de Sanctis U, Salt A, Collin JR, Vivian AJ, Free SL, Thompson P, Williamson KA, Sisodiya SM, van Heyningen V, Fitzpatrick DR (2005) SOX2 anophthalmia syndrome. Am J Med Genet A 135:1–7CrossRefGoogle Scholar
  72. Ramsing M, Rehder H, Holzgreve W, Meinecke P, Lenz W (1990) Fraser syndrome (cryptophthalmos with syndactyly) in the fetus and newborn. Clin Genet 37:84–96CrossRefGoogle Scholar
  73. Reis LM, Semina EV (2015) Conserved genetic pathways associated with microphthalmia, anophthalmia, and coloboma. Birth Defects Res C Embryo Today 105:96–113CrossRefGoogle Scholar
  74. Rieger DK, Reichenberger E, McLean W, Sidow A, Olsen BR (2001) A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice. Genomics 72:61–72CrossRefGoogle Scholar
  75. Roberts RC (1967) Small eyes—a new dominant eye mutant in the mouse. Genet Res Camb 9:121–122CrossRefGoogle Scholar
  76. Rosemann M, Ivashkevich A, Favor J, Dalke C, Hölter SM, Becker L, Rácz I, Bolle I, Klempt M, Rathkolb B, Kalaydjiev S, Adler T, Aguilar A, Hans W, Horsch M, Rozman J, Calzada-Wack J, Kunder S, Naton B, Gailus-Durner V, Fuchs H, Schulz H, Beckers J, Busch DH, Burbach JP, Smidt MP, Quintanilla-Martinez L, Esposito I, Klopstock T, Klingenspor M, Ollert M, Wolf E, Wurst W, Zimmer A, de Angelis MH, Atkinson M, Heinzmann U, Graw J (2010) Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 416insG mice. Mamm Genome 21:13–27CrossRefGoogle Scholar
  77. Semina EV, Murray JC, Reiter R, Hrstka RF, Graw J (2000) Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum Mol Genet 9:1575–1585CrossRefGoogle Scholar
  78. Sheeladevi S, Lawrenson JG, Fielder AR, Suttle CM (2016) Global prevalence of childhood cataract: a systematic review. Eye (Lond) 30:1160–1169CrossRefGoogle Scholar
  79. Sheets NL, Chauhan BK, Wawrousek E, Hejtmancik JF, Cvekl A, Kantorow M (2002) Cataract- and lens-specific upregulation of ARK receptor tyrosine kinase in Emory mouse cataract. Invest Ophthalmol Vis Sci 43:1870–1875Google Scholar
  80. Shiels A, Bassnett S (1996) Mutations in the founder of the MIP gene family underlie cataract development in the mouse. Nat Genet 12:212–215CrossRefGoogle Scholar
  81. Smyth I, Du X, Taylor MS, Justice MJ, Beutler B, Jackson IJ (2004) The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. Proc Natl Acad Sci USA 101:13560–13565CrossRefGoogle Scholar
  82. Solebo AL, Teoh L, Rahi J (2017) Epidemiology of blindness in children. Arch Dis Child 102:853–857CrossRefGoogle Scholar
  83. Steingrímsson E, Copeland NG, Jenkins NA (2004) Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38:365–411CrossRefGoogle Scholar
  84. Sun M, Hölter SM, Stepan J, Garrett L, Genius J, Kremmer E, Hrabě de Angelis M, Wurst W, Lie DC, Bally-Cuif L, Eder M, Rujescu D, Graw J (2013) Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function. Mamm Genome 24:333–348CrossRefGoogle Scholar
  85. Sun M, Ahmad N, Zhang R, Graw J (2018) Crybb2 associates with Tmsb4X and is crucial for dendrite morphogenesis. Biochem Biophys Res Commun 503:123–130CrossRefGoogle Scholar
  86. Takamiya K, Kostourou V, Adams S, Jadeja S, Chalepakis G, Scambler PJ, Huganir RL, Adams RH (2004) A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1. Nat Genet 36:172–177CrossRefGoogle Scholar
  87. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T (1981) A new murine model of accelerated senescence. Mech Ageing Dev 17:183–194CrossRefGoogle Scholar
  88. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR, Pevny LH (2006) SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev 20:1187–1202CrossRefGoogle Scholar
  89. Tucker P, Laemle L, Munson A, Kanekar S, Oliver ER, Brown N, Schlecht H, Vetter M, Glaser T (2001) The eyeless mouse mutation (ey1) removes an alternative start codon from the Rx/rax homeobox gene. Genesis 31:43–53CrossRefGoogle Scholar
  90. Varnum DS, Fox S (1976) heb—head bleb. Mouse News Lett 55:16Google Scholar
  91. Varnum DS, Stevens LC (1968) Aphakia, a new mutation in the mouse. J Hered 59:147–150CrossRefGoogle Scholar
  92. Wada K, Matsushima Y, Tada T, Hasegawa S, Obara Y, Yoshizawa Y, Takahashi G, Hiai H, Shimanuki M, Suzuki S, Saitou J, Yamamoto N, Ichikawa M, Watanabe K, Kikkawa Y (2014) Expression of truncated PITX3 in the developing lens leads to microphthalmia and aphakia in mice. PLoS One 9:e111432CrossRefGoogle Scholar
  93. Williamson KA, FitzPatrick DR (2014) The genetic architecture of microphthalmia, anophthalmia and coloboma. Eur J Med Genet 57:369–380CrossRefGoogle Scholar
  94. Yan X, Sabrautzki S, Horsch M, Fuchs H, Gailus-Durner V, Beckers J, Hrabě de Angelis M, Graw J (2014) Peroxidasin is essential for eye development in the mouse. Hum Mol Genet 23:5597–5614CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019


Authors and Affiliations

  1. 1.Institute of Developmental GeneticsHelmholtz Center Munich, German Research Center for Environmental HealthNeuherbergGermany

Personalised recommendations